Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hirokazu, Hashishita"'
Autor:
SHINYA TAKADA, YOSHIHIRO HOSOKAWA, KENGO UMEHARA, YUTA KIMURA, YUTA FUKAI, KARIN SHIKISHIMA, MITSUGU YAMAMOTO, HIDEKI MAEDA, NOBUMOTO TOMIOKA, KENICHI WATANABE, HIROKAZU HASHISHITA
Publikováno v:
In Vivo; Jan/Feb2024, Vol. 38 Issue 1, p500-505, 6p
Autor:
Shinya, Takada, Hidetaka, Murooka, Kanae, Tahatsu, Maki, Yanase, Kengo, Umehara, Hirokazu, Hashishita, Harabayashi, Toru, Maruyama, Satoru, Tamotsu, Sagawa, Koshi, Fujikawa, Hideki, Sato, Kozo, Mino
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 23:695-701
Neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios can indicate poor disease prognosis and are inflammation markers. We investigated the role of NLR and PLR as effective predictive markers of immune-related adverse event (irAE) on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e528525d115c9b1e345ce1c6bcdce8c3
https://doi.org/10.31557/apjcp.2022.23.2.695
https://doi.org/10.31557/apjcp.2022.23.2.695
Publikováno v:
Urologia Internationalis. 102:435-440
Background: The side effects of sunitinib, namely onset of hypertension and hypothyroidism, have been reported to be predictive biomarkers of treatment efficacy. However, the relationship between hypothyroidism and prolongation of survival in treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83e7d7b0f623526f023085f9a32a1c9f
https://doi.org/10.1159/000499089
https://doi.org/10.1159/000499089
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(7)
Edema is a frequent side effect observed in patients receiving docetaxel hydrate(DTX)treatment. However, the factors contributing to the development of edema in breast cancer patients receiving this treatment have not been completely elucidated. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62775aec204f135de56487833e9c6714
https://pubmed.ncbi.nlm.nih.gov/32668854
https://pubmed.ncbi.nlm.nih.gov/32668854
Autor:
Takada S; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Japan., Hirokazu H; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Japan., Yamagishi K; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Japan., Hideki S; Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Japan., Masayuki E; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Japan.
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2020 Jun 01; Vol. 21 (6), pp. 1697-1699. Date of Electronic Publication: 2020 Jun 01.